DE602007007618D1 - Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis - Google Patents

Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis

Info

Publication number
DE602007007618D1
DE602007007618D1 DE602007007618T DE602007007618T DE602007007618D1 DE 602007007618 D1 DE602007007618 D1 DE 602007007618D1 DE 602007007618 T DE602007007618 T DE 602007007618T DE 602007007618 T DE602007007618 T DE 602007007618T DE 602007007618 D1 DE602007007618 D1 DE 602007007618D1
Authority
DE
Germany
Prior art keywords
treatment
rheumatoid arthritis
liposomal preparations
cationic liposomal
cationic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007007618T
Other languages
English (en)
Inventor
Martin Funk
Brita Schulze
Eric Guenzi
Uwe Michaelis
Hermann Bohnenkamp
Martin Eichhorn
Marcus Schmitt-Sody
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medigene AG
Ludwig Maximilians Universitaet Muenchen LMU
Original Assignee
Medigene AG
Ludwig Maximilians Universitaet Muenchen LMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medigene AG, Ludwig Maximilians Universitaet Muenchen LMU filed Critical Medigene AG
Publication of DE602007007618D1 publication Critical patent/DE602007007618D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602007007618T 2006-05-18 2007-05-18 Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis Active DE602007007618D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80107906P 2006-05-18 2006-05-18
US87932007P 2007-01-09 2007-01-09
PCT/EP2007/004467 WO2007134819A1 (en) 2006-05-18 2007-05-18 Cationic liposomal preparations for the treatment of rheumatoid arthritis

Publications (1)

Publication Number Publication Date
DE602007007618D1 true DE602007007618D1 (de) 2010-08-19

Family

ID=38512671

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007007618T Active DE602007007618D1 (de) 2006-05-18 2007-05-18 Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis

Country Status (5)

Country Link
US (1) US20090232731A1 (de)
EP (1) EP2040674B1 (de)
AT (1) ATE472998T1 (de)
DE (1) DE602007007618D1 (de)
WO (1) WO2007134819A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2086508A2 (de) * 2006-11-03 2009-08-12 MediGene Aktiengesellschaft Kationische kolloidale träger zur abgabe von wirkstoffen an die blut-gehirn-schranke im verlauf von neuroinflammatorischen erkrankungen
US9770414B2 (en) 2010-05-13 2017-09-26 Pacira Pharmaceuticals, Inc. Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent
WO2012058483A1 (en) 2010-10-28 2012-05-03 Pacira Pharmaceuticals, Inc. A sustained release formulation of a non-steroidal anti-inflammatory drug
EP2638896A1 (de) * 2012-03-14 2013-09-18 Bioneer A/S Kationisches liposomales Arzneimittelabgabesystem für spezifisches Targeting humaner CD14+ Monozyten in Vollblut
TWI556838B (zh) 2012-07-05 2016-11-11 台灣微脂體股份有限公司 治療關節炎之方法
KR102109188B1 (ko) 2013-04-01 2020-05-11 삼성전자주식회사 양이온성 지질을 포함하는 온도민감성 리포좀 및 그의 용도
WO2018094253A1 (en) 2016-11-18 2018-05-24 Pacira Pharmaceuticals, Inc. Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same
EP3345614A1 (de) * 2017-01-05 2018-07-11 Amrif B.V. Zusammensetzung mit alkalinphosphatase zur verwendung bei der behandlung von arthritiden
EP3962533A4 (de) * 2019-04-30 2023-01-25 The Medical College of Wisconsin, Inc. Plattform zur verabreichung durch das trommelfell und deren verwendungen
CN113616597A (zh) * 2021-08-02 2021-11-09 上海交通大学 一种美洛昔康的注射剂及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583153A (en) * 1994-10-06 1996-12-10 Regents Of The University Of California Use of taxol in the treatment of rheumatoid arthritis
EP1041976B1 (de) * 1997-12-23 2006-04-05 Inex Pharmaceuticals Corp. Polyamid-oligomere
GB9808268D0 (en) * 1998-04-17 1998-06-17 Imp College Innovations Ltd Compound
US6852334B1 (en) * 1999-04-20 2005-02-08 The University Of British Columbia Cationic peg-lipids and methods of use
CA2406650C (en) * 2000-05-03 2009-07-21 Mbt Munich Biotechnology Ag Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites
EP1374864A1 (de) * 2002-06-26 2004-01-02 Munich Biotech AG Amphiphile, Taxane enthaltende Zusammensetzungen
DE60335279D1 (de) * 2002-06-26 2011-01-20 Medigene Ag Neues verfahren zur stabilisierung von diagnostischen und therapeutischen verbindungen in einem kationischen trägersystem
EP2286794B8 (de) * 2003-10-15 2016-06-01 SynCore Biotechnology CO., LTD Verwendung von kationischen liposomen mit paclitacel
WO2005065721A2 (en) * 2003-12-30 2005-07-21 Board Of Regents, The University Of Texas System Use of an anti-inflammatory compound for the reduction of inflammation secondary to the administration of a lipid-nucleic acid complex

Also Published As

Publication number Publication date
EP2040674B1 (de) 2010-07-07
EP2040674A1 (de) 2009-04-01
WO2007134819A1 (en) 2007-11-29
ATE472998T1 (de) 2010-07-15
US20090232731A1 (en) 2009-09-17

Similar Documents

Publication Publication Date Title
ATE472998T1 (de) Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis
EA200901166A1 (ru) Соединения и композиции в качестве модуляторов активности gpr 119
EA201390772A1 (ru) Новые соли и полиморфные формы афатиниба
EA201300471A1 (ru) Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3
EA200700035A1 (ru) Сульфаматные и сульфамидные производные для лечения эпилепсии и родственных di sorders
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
EA201790267A1 (ru) Новые модуляторы киназ
EA201071264A1 (ru) Аминодигидротиазиновые производные в качестве ингибиторов bace для лечения болезни альцгеймера
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA201490922A1 (ru) ПРОИЗВОДНЫЕ ГИДАНТОИНА, ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Kv3-КАНАЛОВ
ATE550338T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
EA201170624A1 (ru) Изоникотинамидные антагонисты рецепторов орексинов
EA201071245A1 (ru) Новые терапевтические подходы для лечения болезни альцгеймера и связанных нарушений посредством модулирования реакции клеток на стресс
TW200612905A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
EA200971077A1 (ru) Гетероциклические модуляторы киназы
EA201070822A1 (ru) Доставка антител посредством модульного домена распознавания
EA200970738A1 (ru) Ингибиторы активности akt
EA200900959A1 (ru) Ингибиторы мек
EA201100062A1 (ru) Соединения и способы модулирования рецепторов, связанных с белком g
ATE534633T1 (de) Indazolderivate zur behandlung von hsp90- induzierten krankheiten
ATE512948T1 (de) Biphenyl-sulfonyl- und phenyl-heteroaryl-sulfonyl-modulatoren des histamin-h3-rezeptors zur behandlung von damit verbundenen erkrankungen
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
MX2009003981A (es) Agentes moduladores del receptor de calcio.
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser